title: Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry.
abstract: Direct-to-consumer marketing of unapproved stem cell interventions is a well-known phenomenon in countries with lax medical regulations. However, an examination of Internet-based marketing claims revealed widespread promotion of such interventions by businesses based in the United States. Such commercial activity suggests that regulatory agencies must better oversee this marketplace.
authors.affiliation: Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: turne462@umn.edu.
authors.forename: Leigh
authors.initials: L
authors.lastname: Turner
authors.affiliation: Department of Cell Biology and Human Anatomy, University of California, Davis, Davis, CA 95616, USA; Institute of Pediatric Regenerative Medicine, Shriners Hospital For Children Northern California, Sacramento, CA 95817, USA. Electronic address: knoepfler@ucdavis.edu.
authors.forename: Paul
authors.initials: P
authors.lastname: Knoepfler
mesh_terms: D004345:Drug Industry / Q000191:economics* / Q000941:ethics / Q000331:legislation & jurisprudence; D005843:Geography; D006801:Humans; D040541:Marketing / Q000941:ethics / Q000331:legislation & jurisprudence; D057766:Policy; D012306:Risk; D013234:Stem Cells / Q000166:cytology*; D014481:United States